A PHASE I-II STUDY OF INTENSIVE-DOSE ADRIAMYCIN FOR ADVANCED BREAST-CANCER

被引：130

作者：

JONES, RB

HOLLAND, JF

BHARDWAJ, S

NORTON, L

WILFINGER, C

STRASHUN, A

机构：

[1] CUNY MT SINAI SCH MED, ANDRE MEYER DEPT NUCL MED, NEW YORK, NY 10029 USA

[2] CUNY MT SINAI SCH MED, DEPT NEOPLAST DIS, NEW YORK, NY 10029 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1987年 / 5卷 / 02期

关键词：

D O I：

10.1200/JCO.1987.5.2.172

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：172 / 177

页数：6

共 32 条

[1]

BUNN PA, 1978, SEMIN ONCOL, V5, P314

[2] POST-OPERATIVE ADJUVANT CHEMOTHERAPY WITH FLUOROURACIL, DOXORUBICIN, CYCLOPHOSPHAMIDE, AND BCG VACCINE - FOLLOW-UP REPORT [J].

BUZDAR, AU ;

BLUMENSCHEIN, GR ;

GUTTERMAN, JU ;

TASHIMA, CK ;

HORTOBAGYI, GN ;

SMITH, TL ;

CAMPOS, LT ;

WHEELER, WL ;

HERSH, EM ;

FREIREICH, EJ ;

GEHAN, EA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 242 (14) :1509-1513

[3]

CARPENTER JT, 1982, CANCER, V50, P18, DOI 10.1002/1097-0142(19820701)50:1<18::AID-CNCR2820500105>3.0.CO

[4]

2-J

[5]

CARREOPEREIRA J, 1986, P AN M AM SOC CLIN, V5, P56

[6] The use of confidence or fiducial limits illustrated in the case of the binomial. [J].

Clopper, CJ ;

Pearson, ES .

BIOMETRIKA, 1934, 26 :404-413

[7]

CORTES EP, 1978, CANCER TREAT REP, V62, P271

[8]

CREECH RH, 1979, CANCER, V43, P51, DOI 10.1002/1097-0142(197901)43:1<51::AID-CNCR2820430107>3.0.CO

[9]

2-N

[10] DOSE - A CRITICAL FACTOR IN CANCER-CHEMOTHERAPY [J].

FREI, E ;

CANELLOS, GP .

AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) :585-594

← 1 2 3 4 →